lorazepam has been researched along with indocyanine green in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (27.27) | 18.7374 |
| 1990's | 6 (54.55) | 18.2507 |
| 2000's | 1 (9.09) | 29.6817 |
| 2010's | 1 (9.09) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| DiPiro, JT; Gaines, MG; Hooker, KD; Sherman, JC; Wynn, JJ | 1 |
| Boucher, BA; Fabian, TC; Kuhl, DA; Robertson, JT | 1 |
| Crom, WR; Evans, WE; Kearns, GL; Mallory, GB | 1 |
| Awni, WM; Bakker, LJ | 1 |
| Crom, WR; Cupit, GC; Evans, WE; Pieper, JA; Relling, MV; Rivera, GK | 1 |
| Bobo, L; Crom, WR; Evans, WE; Relling, MV; Teresi, ME; Webster, SL | 1 |
| Crom, WR; Evans, WE; Karlson, KH; Kearns, GL; Mallory, GB | 1 |
| Bhargava, R; Crom, WR; Evans, WE; Murry, DJ; Reddick, WE | 1 |
| Adams, MH; Ferry, JJ; Garnett, WR; Karnes, HT; Poynor, WJ; Ryan, KK; Sarkar, MA | 1 |
1 review(s) available for lorazepam and indocyanine green
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 trial(s) available for lorazepam and indocyanine green
| Article | Year |
|---|---|
Pharmacokinetics of minoxidil in patients with cirrhosis and healthy volunteers.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Antipyrine; Area Under Curve; Biotransformation; Coloring Agents; Female; GABA Modulators; Half-Life; Humans; Indocyanine Green; Liver Cirrhosis; Liver Function Tests; Lorazepam; Male; Middle Aged; Minoxidil; Vasodilator Agents | 1998 |
9 other study(ies) available for lorazepam and indocyanine green
| Article | Year |
|---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Effect of experimental hemorrhagic shock on hepatic drug elimination.
Topics: Animals; Antipyrine; Chromatography, High Pressure Liquid; Disease Models, Animal; Female; Half-Life; Indocyanine Green; Liver; Lorazepam; Male; Metabolic Clearance Rate; Shock, Hemorrhagic; Spectrophotometry, Ultraviolet; Swine; Time Factors | 1992 |
Effect of neurotrauma on hepatic drug clearance.
Topics: Adult; Aged; Antipyrine; C-Reactive Protein; Craniocerebral Trauma; Humans; Indocyanine Green; Liver; Lorazepam; Male; Metabolic Clearance Rate; Middle Aged; Orosomucoid | 1991 |
Enhanced hepatic drug clearance in patients with cystic fibrosis.
Topics: Adolescent; Adult; Antipyrine; Biotransformation; Cystic Fibrosis; Female; Humans; Indocyanine Green; Infusions, Intravenous; Liver; Lorazepam; Male; Neoplasms; Tissue Distribution | 1990 |
Antipyrine, indocyanine green, and lorazepam determined in plasma by high-pressure liquid chromatography.
Topics: Antipyrine; Chromatography, High Pressure Liquid; Humans; Indocyanine Green; Liver; Liver Function Tests; Lorazepam; Pyrenes; Statistics as Topic | 1989 |
Hepatic drug clearance in children with leukemia: changes in clearance of model substrates during remission-induction therapy.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Antipyrine; Blood Proteins; Child; Child, Preschool; Drug Interactions; Female; Humans; Indocyanine Green; Leukemia, Lymphoid; Liver; Lorazepam; Male; Metabolic Clearance Rate; Protein Binding | 1987 |
Simultaneous administration of multiple model substrates to assess hepatic drug clearance.
Topics: Administration, Oral; Adult; Allopurinol; Antipyrine; Drug Interactions; Humans; Indocyanine Green; Infusions, Intravenous; Liver; Lorazepam; Male; Metabolic Clearance Rate | 1987 |
Hepatic drug clearance in patients with mild cystic fibrosis.
Topics: Adolescent; Adult; Anti-Anxiety Agents; Anti-Inflammatory Agents, Non-Steroidal; Antipyrine; Bile; Child; Chromatography, High Pressure Liquid; Coloring Agents; Cystic Fibrosis; Cytochrome P-450 Enzyme System; Female; Humans; Indocyanine Green; Infusions, Intravenous; Liver; Lorazepam; Male; Regression Analysis; Structure-Activity Relationship | 1996 |
Liver volume as a determinant of drug clearance in children and adolescents.
Topics: Adolescent; Age Factors; Antipyrine; Child; Child, Preschool; Female; Humans; Indocyanine Green; Liver; Lorazepam; Male; Metabolic Clearance Rate | 1995 |